IL23A and skin disorder: This study provided the first evidence that topical Cal/BDP caused synergistic improvement of IMQ-induced psoriasis-like dermatitis in vivo while suppressing the expression of cytokines related to the IL-23/T17 pathogenic axis, such as IL-17a and IL-23a, in psoriatic lesions.